Summary
The European Parliament opposes the authorization of complex genetically modified maize products due to scientific data gaps and health concerns. 10 05.04.2017
Other
health
environment
agriculture, forestry and fisheries
Key points
- The European Parliament opposes the authorization of complex genetically modified maize varieties for food and feed use.
- There is a critical lack of specific scientific data for many of the twenty proposed sub-combinations of the maize.
- Scientific experts have raised concerns regarding potential risks to human health, such as increased allergenicity and toxicity.
- The crops are designed to be tolerant to glufosinate, a substance classified as toxic to reproduction.
Documents (PDFs)
MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize Bt11 × 59122 × MIR604 × 1507 × GA21, and genetically modified maizes combining two, three or four of the events Bt11, 59122, MIR604, 1507 and GA21, pursuant to Regulation (EC) No 1829/2003 of the European parliament and of the Council on genetically modified food and feed
Genetically modified maize Bt11 × 59122 × MIR604 × 1507 × GA21
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.